Ibogaine

Many factors contribute to the ibogaine and iboga experiences, including dose, mindset, setting, and method of consumption. With that in mind, each individual journey will be unique to the person, time, and place, and there’s no way to predict exactly what will happen. It’s also important to note the difference between iboga and ibogaine, each of which has a different makeup and use case. However, ibogaine and iboga do induce some common experiences and effects that can help you prepare for your journey. 

Ibogaine

Ibogaine for sale is just one alkaloid from the iboga plant and is used almost exclusively in medical settings to treat addiction. It’s produced semi-synthetically, which ensures precise dosing. A typical dose is 15-20 mg per kg which is much less than its natural counterpart, making it crucial for people to be careful with their dosing.

The ibogaine experience can last 24 hours or more—and it isn’t known for being pleasant. One of the most immediate adverse effects you may feel is ataxia, or an inability to fluidly coordinate muscle movements. Nausea, dry mouth, dizziness, heartbeat irregularities, irregular breathing, and vomiting are also common side effects.

It’s best to lay down during an ibogaine experience, as sudden movements can lead to increased dizziness and nausea. You can expect to be in bed for the first 12 hours of your trip (phases 1 and 2 below). The first several hours will be intense before you start to come down as your body metabolizes the ibogaine.

A trip can be broken down into three phases:

1. Acute, “awakened dream state” phase
2. Evaluative or reflective phase
3. Residual stimulation phase

Phase 1: Acute phase. The acute phase begins 1 to 3 hours after taking Ibogaine for sale and can last 4 to 8 hours. Most report a “panoramic,” mostly visual experience of past memories during this time. It’s often described as a “waking dream” state with varying experiences that might include contact with transcendent beings, passage along a lengthy path, or floating.

People often report being placed in or entering visual landscapes, rather than experiencing intrusive visual or auditory hallucinations. Not all subjects experience visual phenomena, which may be related to dose, bioavailability, and interindividual variation.

Phase 2: Evaluative phase. The evaluative phase begins approximately 4 to 8 hours after taking ibogaine and can last 8 to 20 hours. People often report recalling fewer memories in this phase along with a more neutral and reflective emotional tone. Attention is directed at evaluating the experiences of the acute phase. Many prefer as little environmental stimuli during this phase and the acute phase as it’s easy to become agitated or annoyed by distractions.

Phase 3: Residual stimulation phase. The residual stimulation phase begins approximately 12 to 24 hours after taking ibogaine and can last 24 to 72 hours or more. Attention shifts back to the external environment during this phase while the subjective psychoactive experience begins to fade. Normal movement returns and people often report heightened arousal and vigilance during this period as well. Some say their need for sleep drops for several days to weeks following treatment.

After a trip is complete, a window of heightened introspection opens that can last several days to weeks, allowing the person to integrate these new perspectives about the issues they face into their daily lives.

Iboga

While ibogaine is an isolated alkaloid extracted from the iboga plant, iboga itself contains 11 more alkaloids that many believe are essential elements of the plant’s therapeutic qualities. Some research shows that the alkaloid tabernanthine, for example, may have active properties similar to ibogaine.  These additional alkaloids also make for a more hallucinatory experience, which is one reason iboga is considered a plant medicine capable of fostering personal and spiritual growth rather than just treating addiction. However, iboga has successfully been used in the treatment of addiction and ibogaine has been used for other forms of psychological healing.

Doses of iboga range between 5-100 grams depending on what is being treated. This can require the consumption of a large amount of iboga root bark, which can be difficult as well as unpredictable—the amount of active chemicals varies between individual plants, making it hard to administer the right amount. Consuming so much of the bark also seems more likely to cause the adverse physical symptoms associated with ibogaine, including nausea, vomiting, and loss of muscle control. But many believe these effects are an important element of the therapeutic outcome—less purging, less healing.

The phases of the iboga journey are similar to ibogaine, but with a heightened intensity. Though ibogaine does produce visuals, iboga is known for its intense psychedelic experience and vivid hallucinations. With a large dose, the course of the iboga journey will also be longer than that of ibogaine. It’s common for the experience to last 72 hours, and for the afterglow to last for weeks. For these reasons, it’s believed that half the people who take ibogaine will not have a typically spiritual experience.

Ibogaine interacts with several neurotransmitter systems simultaneously with its highest affinity being for the sigma-2 receptor. It has a moderate affinity for opioid receptors and a moderate-to-low affinity for serotonin receptors.

Ibogaine is metabolized by the body into noribogaine, which acts to increase the availability of serotonin in the brain.

Interactions with other drugs

Ibogaine is metabolized in part by the awkwardly named enzyme cytochrome P4502D6, which is involved in the metabolism of a whole host of other medications and chemicals in the body. That means the list of ibogaine’s dangerous interactions is long.

The risk of experiencing cardiac complications or other dangerous side effects increases when ibogaine is taken in conjunction with antiarrhythmic drugs, anti-depressants, anti-psychotics, and more. Cardiac complications can also be triggered by foods containing bergamottin or bergamot oil, such as grapefruit juice, as well as a variety of other supplements and over-the-counter medications, including Prilosec (Omeprazole), some gastric disorder drugs, anti-fungal medications, HIV treatment drugs, and some antihistamines. This is by no means a complete list of dangerous interactions with ibogaine, and use of the drug should only be considered after proper medical screening and with proper medical support.

Potential Benefits Of Ibogaine For Sale

Iboga

Like many psychedelics, iboga has traditionally been used in ceremonial and religious contexts to connect the user to a higher level of spirituality and a deeper understanding of the self. This usually comes about due to the personal insights gained in the egoless state that iboga can produce—people often receive powerful insights into the personal issues they’re facing and feel a greater connection to the world around them. In this context, iboga can help spark personal growth in myriad forms—it’s helped people deal with depression, anxiety, PTSD, indulgent behaviors, and much more.

Ibogaine For Sale

Ibogaine is more widely known as a treatment for addiction, which is becoming more prevalent and in-demand as anecdotal and some clinical evidence suggests its efficacy. Though it’s by no means a panacea for chronic substance use disorders, it does have a high success rate when it comes to easing the withdrawal process for people detoxing from opiates, cocaine, amphetamines, and alcohol. For some, the ibogaine experience completely erases withdrawal symptoms, while many others simply experience less intense cravings. While more research is needed to determine exactly how effective ibogaine treatment is for both addiction and personal benefit, its potential as an agent for healing and change is promising.

Risks

Ibogaine is one of the most powerful and medically volatile medicines, according to author and plant medicine facilitator Elizabeth Bast. While that makes its therapeutic potential high, ibogaine use isn’t without risk and must be treated with care and attention. Reports of toxicity-related complications caused by ibogaine have largely been due to previous medical conditions (mostly cardiac), as well as drug-drug interactions. It is very important to avoid using ibogaine if you have a pre-existing heart condition. The combination can be lethal.

A review that looked at medical records from 1990 to 2008 found that 19 people died anywhere from about an hour to three days after using ibogaine. However, none of these deaths could be attributed to toxic effects of the drug itself, but rather to interactions either with prior medical conditions or other drugs.

However, there are also reports of people suffering a fatal reaction to ibogaine even after a medical screening. It’s estimated that up to 1 in 400 people who take ibogaine suffer a fatal reaction, which makes it a higher risk endeavor than most extreme sports.

While ibogaine’s therapeutic applications are nothing new, it’s reputation as a powerful medicine continues to be proven. From a therapeutic standpoint, ibogaine has mostly been used to treat addiction. This application has largely been used to treat opiate addictions, but it’s also been shown to be an effective treatment for cocaine, amphetamines, and alcohol abuse as well. Calling it an addiction “cure” would be going too far, however; instead, it’s often called an addiction “interrupter,” as it eliminates or greatly reduces withdrawal symptoms of opiates, cocaine, amphetamines, and alcohol.

Some people have experienced the permanent eradication of withdrawal symptoms after a single treatment session, but more often, cravings and other symptoms return after a few weeks or months, but at greatly reduced intensities.

Research into ibogaine’s therapeutic potential is limited, though. The drug is categorized as a Schedule I drug in the U.S., and since NIDA pulled research funding for ibogaine as a possible addiction treatment in 1995, there have been no systematic controlled trials on its anti-addictive effects and efficacy in the U.S. or Europe.

Ibogaine success rate

Due to its status as a Schedule I drug, ibogaine has primarily been used as a treatment for addiction in non-traditional clinical settings outside of the United States. Statistics on its efficacy, therefore, are somewhat difficult to come by.

Two studies conducted by MAPS in Mexico and New Zealand found significant long-term reduction of withdrawal symptoms in 20% and 50% of participants, respectively.

Another recent study in Brazil found that a combination of ibogaine and psychotherapy led to the long-term reduction of symptoms in over 60% of participants, highlighting ibogaine’s potential as a supplementary tool in overcoming addiction.

A recent observational study of people with chronic addiction from the Johns Hopkins School of Medicine also suggests that ibogaine treatment can significantly improve opioid abstinence. Of 88 subjects interviewed, 80% reported that ibogaine either drastically reduced or totally abated their withdrawal symptoms, with 30% abstaining from opioid use for years following the treatment.

In combination with social support and a structured treatment plan that focuses on long-term goals, ibogaine is showing tremendous promise in treating addiction.

Ibogaine treatment centers

As of now, there are some 75 to 100 ibogaine treatment facilities around the world. In recent years, new treatment centers outside of the United States have been popping up quickly to meet the growing demand for ibogaine treatment.

Choosing a treatment facility depends somewhat on a host of personal decisions and preferences, but any treatment center you consider should, first and foremost, adhere to the guidelines set forth by The Global Ibogaine Therapy Alliance for clinical treatment with ibogaine.

Like any industry that sees rapid expansion, there are varying degrees of quality and efficacy in the ibogaine treatment industry. Also like other areas of the healthcare industry, it’s not without its unethical players. Due diligence is required to find the facility and provider that best fits your individual needs. Below is a list of a handful with an established track record that have received good reviews for their quality of treatment and high ethical standards. These are not recommendations, but a starting point for your own research.

Ibogaine Treatment Centers in Canada

• Sacred Soul Therapy House – Vancouver, Canada
• Toronto Ibogaine Centre – Toronto, Canada
• Liberty Root Ibogaine Therapy – Vancouver, Canada

Ibogaine Treatment Centers in Mexico and Caribbean

• Crossroads Treatment Center – Bahamas, Caribbean
• Clear Skies Recovery – Cancun, Mexico
• Experience Treatment Center – Rosarito, Mexico
• Holistic Hope House – Rosarito, Mexico

Ibogaine Treatment Centers in Europe

• Tabula Rasa – Portugal
• Iboga Tree Healing House – Portugal